2023
Racioethnic differences in missing data in the national cancer database: A window into inequities in cancer care.
Raman V, Migaly J, Greenup R, Tong B, Fayanju O. Racioethnic differences in missing data in the national cancer database: A window into inequities in cancer care. Journal Of Clinical Oncology 2023, 41: e18502-e18502. DOI: 10.1200/jco.2023.41.16_suppl.e18502.Peer-Reviewed Original ResearchNational Cancer DatabaseHispanic patientsCancer careClinical stagingWhite patientsCancer DatabaseTreatment statusTreatment documentationMultivariable logistic regression modelGuideline-concordant careMultivariable logistic regressionDiagnosis of cancerNon-Hispanic whitesLogistic regression modelsRace/ethnicityPrimary outcomeLung cancerObservational studyStudy populationPatientsStage ILogistic regressionPearson's ChiCompleteness of dataStudy of cancer
2014
Cost Implications of the SSO-ASTRO Consensus Guideline on Margins for Breast-Conserving Surgery with Whole Breast Irradiation in Stage I and II Invasive Breast Cancer
Greenup R, Peppercorn J, Worni M, Hwang E. Cost Implications of the SSO-ASTRO Consensus Guideline on Margins for Breast-Conserving Surgery with Whole Breast Irradiation in Stage I and II Invasive Breast Cancer. Annals Of Surgical Oncology 2014, 21: 1512-1514. PMID: 24577813, DOI: 10.1245/s10434-014-3605-x.Peer-Reviewed Original Research
2012
Association of pathologic complete response following neoadjuvant chemotherapy with survival among young women with breast cancer.
Greenup R, Bardia A, Buckley J, Niemierko A, Camp M, Coopey S, Gadd M, Schapira L, Taghian A, Smith B, Specht M. Association of pathologic complete response following neoadjuvant chemotherapy with survival among young women with breast cancer. Journal Of Clinical Oncology 2012, 30: 1122-1122. DOI: 10.1200/jco.2012.30.15_suppl.1122.Peer-Reviewed Original ResearchPathologic complete responseNeoadjuvant chemotherapyOverall survivalBreast cancerComplete responseYoung womenAdjuvant chemotherapyHazard ratioHER-2Stage IYoung breast cancer patientsTriple-negative breast cancerNeo-adjuvant chemotherapyTiming of chemotherapyBreast cancer patientsState tumor registryFinal pathologic reviewDeath certificate dataNegative breast cancerValuable surrogate markerOS ratesPathologic reviewSystemic therapyTumor RegistryDeath Index